Persones / Equip Humà

Marçal Pastor-Anglada

Buscador de publicacions

Publicacions

  • Pinilla-Macua I, Claudio-Montero A and Pastor-Anglada M.

    rCNT2 extracellular cysteines, Cys(615) and Cys(649), are important for maturation and sorting to the plasma membrane.

    FEBS LETTERS . 588(23): 4382-4389. Nº de cites: 2

    [doi:10.1016/j.febslet.2014.10.006]

  • Wojtal KA, Cee A, Lang S, Götze O, Frühauf H, Geier A, Pastor-Anglada M, Torres-Torronteras J, Martí R, Fried M, Lutz TA, Maggiorini M, Gassmann M, Rogler G and Vavricka SR.

    Downregulation of duodenal SLC transporters and activation of proinflammatory signaling constitute the early response to high altitude in humans.

    AM J PHYSIOL-GASTR L . 307(7): . Nº de cites: 29

    [doi:10.1152/ajpgi.00353.2013]

  • Pinilla-Macua I, Fernández-Calotti P, Pérez-Del-Pulgar S and Pastor-Anglada M.

    Ribavirin uptake into human hepatocyte HHL5 cells is enhanced by interferon-a via up-regulation of the human concentrative nucleoside transporter (hCNT2).

    MOLECULAR PHARMACEUTICS . 11(9): 3223-3230. Nº de cites: 7

    [doi:10.1021/mp500263p]

  • Arimany-Nardi C, Errasti-Murugarren E, Minuesa G, Martinez-Picado J, Gorboulev V, Koepsell H and Pastor-Anglada M.

    Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors.

    BRITISH JOURNAL OF PHARMACOLOGY . 171(16): 3868-3880. Nº de cites: 17

    [doi:10.1111/bph.12748]

  • Medina-Pulido L, Molina-Arcas M, Justicia C, Soriano E, Burgaya F, Planas AM and Pastor-Anglada M.

    Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cells.

    BIOCHEMICAL JOURNAL . 454(3): 437-445. Nº de cites: 22

    [doi:10.1042/BJ20130231]

  • Perez-Torras S, Vidal-Pla A, Cano-Soldado P, Huber-Ruano I, Mazo A and Pastor-Anglada M.

    Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner.

    CELL DEATH & DISEASE . 4: . Nº de cites: 23

    [doi:10.1038/cddis.2013.173]

  • Cárdenas A, Toledo C, Oyarzún C, Sepúlveda A, Quezada C, Guillén-Gómez E, Díaz-Encarnación MM, Pastor-Anglada M and San Martín R.

    Adenosine A(2B) receptor-mediated VEGF induction promotes diabetic glomerulopathy.

    LABORATORY INVESTIGATION . 93(1): 135-144. Nº de cites: 35

    [doi:10.1038/labinvest.2012.143]

  • Huber-Ruano I, Errasti-Murugarren E, Godoy V, Vera Á, Andreu AL, Garcia-Arumi E, Martí R and Pastor-Anglada M.

    Functional outcome of a novel SLC29A3 mutation identified in a patient with H syndrome.

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS . 428(4): 532-537. Nº de cites: 9

    [doi:10.1016/j.bbrc.2012.09.143]

  • Martinez-Becerra P, Monte I, Romero MR, Serrano MA, Vaquero J, Macias RI, Del Rio A, Grañé-Boladeras N, Jimenez F, San-Martin FG, Pastor-Anglada M and Marin JJ.

    Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy.

    PHARMACOLOGICAL RESEARCH . 66(5): 419-427. Nº de cites: 10

    [doi:10.1016/j.phrs.2012.07.005]

  • Trigueros-Motos L, Perez-Torras S, Casado FJ, Molina-Arcas M and Pastor-Anglada M.

    Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.

    BMC Cancer . 12: 434-434. Nº de cites: 24

    [doi:10.1186/1471-2407-12-434]